Skip to content

Efficacy and safety of the Deshutuo appliance in preventing peristomal complications after colostomy: a randomized, open-label, parallel, positive-controlled, multicenter, noninferiority trial

Efficacy and safety of the Deshutuo appliance in preventing peristomal complications after colostomy: a randomized, open-label, parallel, positive-controlled, multicenter, noninferiority trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069297
Enrollment
Unknown
Registered
2023-03-13
Start date
2021-03-17
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peristomal complication

Interventions

Experimental group:Deshutuo two-piece ostomy appliance
Control group:SenSura two-piece ostomy appliance

Sponsors

Hu'nan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >=18 years, no gender limit; 2. Patients in the perioperative period after the first elective single cavity colostomy at each study center; 3. The seated stoma height of the patient was >=0.5cm above the skin surface; 4. The DET score of periostomy dermatitis was 0; 5. Karnofsky score >=70; 6. The local conditions of the stoma meet the requirements of using the planar chassis; 7. The patient participated in the experiment voluntarily and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergic to any product used in the test or allergic to two or more drugs, foods, etc.; 2. Patients who need reoperation due to any disease after ostomy; 3. Patients in the stage of acute infection, surgical incision infection, lung infection and other severe infections; 4. Patients with existing underlying diseases (such as diabetes, chronic obstructive pulmonary disease, hypertension, cerebral infarction, coronary heart disease, etc.) have not been effectively controlled, and are judged by researchers to be unfit to participate in this study; 5. Patients with mental abnormality or unstable condition; 6. Patients with a history of drug abuse, drug abuse, and serious infectious disease are still clinically significant according to researchers' judgment; 7. Pregnant and lactating patients and those who have recently planned to give birth; 8. Patients have participated in clinical trials of other medical devices within 1 month before screening or clinical trials of other drugs within 3 months before screening; 9. Due to various subjective and objective factors, patients and their families cannot cooperate with research; 10. Patients deemed unsuitable for this clinical trial by the investigator.

Design outcomes

Primary

MeasureTime frame
1 - peristomal dermatitis rate;

Secondary

MeasureTime frame
Baseplate leakage degree;Average lasting period of the baseplate;Economic parameters;Patient satisfactory degree;

Countries

China

Contacts

Public ContactShen Yongyi

Hu'nan Cancer Hospital

zyy_hn@163.com+86 189 7518 5580

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026